GlassScriptPhysician profile
Keith T Bopf
NPI 1336213420
$5,872.72
in general payments reported to CMS, 2019-2025
35 companies · $680 in 2025
The $680 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $851 · 2021: $1,289 · 2022: $935 · 2023: $885 · 2024: $717 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,281.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $795.41 | 2019-2025 | Esprit, Jeti |
| Smith+Nephew, INC. | $590.56 | 2019-2024 | Oasis, Regranex |
| Stryker Corporation | $306.31 | 2021-2025 | Prophecy, Ortholoc 3di, Pangea |
| Bard Peripheral Vascular, INC. | $299.11 | 2020-2023 | Lutonix Drug Coated Balloon |
| Kerecis Limited | $286.25 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Biotissue Holdings INC. | $237.37 | 2021 | |
| Paratek Pharmaceuticals, INC. | $226.95 | 2021-2024 | Nuzyra |
| Abbvie INC. | $204.75 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $201.21 | 2020 | |
| Integra Lifesciences Corporation | $199.93 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $178.44 | 2022-2023 | N/A, Hammerlock, Vivigen Mis Delivery System |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $178.41 | 2019-2021 | |
| Wright Medical Technology, INC. | $161.68 | 2019 | |
| Paragon 28, INC. | $155.78 | 2022-2023 | |
| Globus Medical, INC. | $147.74 | 2025 | Senza |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $142.25 | 2022 | |
| Progenacare Global, LLC | $136.62 | 2023 | |
| Treace Medical Concepts, INC. | $126.40 | 2024 | |
| Averitas Pharma INC. | $121.83 | 2023 | Qutenza |
| Amgen INC. | $116.80 | 2024 | Krystexxa |
| Misonix INC | $113.97 | 2021 | |
| Anika Therapeutics, INC. | $105.84 | 2022 | |
| Grt US Holding, INC. | $99.96 | 2022 | |
| Linvatec Corporation | $99.35 | 2024 | Biobrace 23mm |
| Organogenesis INC. | $93.90 | 2022 | |
| Eclipse Technology Solutions INC. | $85.21 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $83.98 | 2023-2025 | Zerbaxa, Dificid, Recarbrio |
| Allergan, INC. | $63.87 | 2019 | |
| Trilliant Surgical LLC. | $60.70 | 2021 | |
| Urgo Medical North America, LLC | $50.97 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Davol INC. | $48.91 | 2023 | Arista Ah Flexitip |
| Next Science LLC | $46.67 | 2022 | |
| Hartmann USA, INC. | $44.09 | 2022 | |
| Medline Industries LP | $43.58 | 2023 | |
| Kci USA, INC. | $17.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Bopf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.